Corrigendum to "Cetuximab in locally advanced head and neck squamous cell carcinoma: Biological mechanisms involved in efficacy, toxicity and resistance" [Crit. Rev. Oncol./Hematol. 164 (2021) 1-11/103424].

Crit Rev Oncol Hematol

Department of Radiation Oncology, CRO Aviano National Cancer Institute, Aviano, PN, Italy.

Published: October 2021

Download full-text PDF	Source
http://dx.doi.org/10.1016/j.critrevonc.2021.103479	DOI Listing

Publication Analysis

corrigendum "cetuximab

"cetuximab locally

locally advanced

advanced head

head neck

neck squamous

squamous cell

cell carcinoma

carcinoma biological

biological mechanisms

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!